Inventor · disambiguated record
David J. Fontana
Also filed as: FONTANA DAVID · FONTANA DAVID J
4 granted patents·5 pending applications·45 citations·filing 2006–2025
78Inventor score
Top patents by PatentIndex Score
9 records- 0196US11274152B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Mar 15, 2022·6 cites·12 claims
- 0293US10081681B2Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Sep 25, 2018·17 cites·18 claims
- 0388US7998939B2Aptamers that bind thrombin with high affinityARCHEMIX CORP·Filed 2006·Granted Aug 16, 2011·16 cites·30 claims
- 0481US10869924B2PD-L1 antagonist combination treatmentsMERCK PATENT GMBH·Filed 2016·Granted Dec 22, 2020·6 cites·24 claims
- 0577US2022185892A1Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat TumorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0674US2025163155A1Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 0764US2020062845A1Combination of anti-lag-3 antibodies and anti-pd-1 antibodies to treat tumorsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 0852US2021069326A1Pd-l1 antagonist combination treatmentsMERCK PATENT GMBH·Filed 2020·Application pending·0 cites
- 0939US2012149764A1Aptamers that bind thrombin with high affinityDIENER JOHN L·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →